ReviewAnimals : an open access journal from MDPI2024
Factors Influencing Contrast Enhancement in Abdominal Computed Tomography Angiography in the Dog: A Systematic Review.
Review in Animals : an open access journal from MDPI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Practical Weakly Supervised Framework for Dose-Up Translation of Low-Enhanced CT Under Clinical Acquisition Variability.Journal of imaging · 2026Article
- Triple-phase contrast-enhanced computed tomography findings for feline cranial mediastinal tumors: Pilot study.The Canadian veterinary journal = La revue veterinaire canadienne · 2026Article
- Optimization of Contrast Injection Protocols for Time-Resolved MRA Technique in Dogs: A Comparative Study of Vascular Signal Characteristics and Artifacts.Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association · 2026Article
- Triple-phase contrast-enhanced computed tomography findings in dogs with cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: Pilot study.Open veterinary journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multidetector-row computed tomographic angiography (angio-CT) aims to achieve optimal opacification of the vascular compartment of interest. The distribution and quality of vascular opacification are influenced by patient-related factors, contrast medium (CM)-related factors, and scanner-related factors. This systematic review evaluates these factors and their effects on contrast enhancement. A comprehensive literature search was made in February 2024 across four online bibliographic databases (Web of Science, PubMed, Scopus, and CAB Abstract) in adherence with the PRISMA 2020 guidelines. After screening the 5990 unique published articles initially identified, 20 full-text original studies met the inclusion criteria for the final review. The amount of abdominal adipose tissue was found to significantly affect enhancement, which suggests the possibility of reducing the CM dose to minimize adverse effects or toxicity. The injection rate of the CM, rather than the injection duration, was identified as the most critical factor, with important clinical implications. For scanners with slower acquisition speeds or longer scan durations, maintaining a fixed CM injection duration may optimize vascular phase acquisition. In contrast, faster scanners benefit from bolus tracking, which allows for improved differentiation between vascular phases. Additionally, administering a saline flush post-CM injection enhances arterial opacification while reducing the necessary CM dose. This systematic review highlights essential factors influencing contrast enhancement in angio-CT for dogs and provides a foundation for future research aimed at optimizing imaging protocols in veterinary medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.